Stockreport

Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M [Seeking Alpha]

Bioventus Inc. - Class A  (BVS) 
PDF On an organic basis, revenue increased 14.3%, driven by more than 20% growth in Pain Treatments and Surgical Solutions. Bioventus introduced its financial guidance fo [Read more]